Lonza · 10 hours ago
Director, Regulatory Affairs
Lonza is a leader in life sciences, and they are seeking a Director of Regulatory Affairs to lead regulatory strategies that ensure compliance and accelerate the delivery of life-changing medicines. The role involves monitoring regulations, representing the company in negotiations, and overseeing regulatory submissions while collaborating with various teams.
BiotechnologyLife SciencePharmaceutical
Responsibilities
Monitor global and regional regulations to ensure compliance and identify emerging risks
Represent Lonza in interactions with Health Authorities and lead regulatory negotiations
Develop and implement regulatory strategies that enable successful drug product submissions and support ongoing lifecycle management for our customers
Oversee preparation and review of Chemistry, Manufacturing, and Controls (CMC) submissions
Collaborate with Quality, Operations, and R&D to align regulatory strategies with business goals
Mentor and lead the Regulatory Affairs team, fostering professional growth and excellence
Drive continuous improvement initiatives within regulatory processes
Qualification
Required
Bachelor's degree in chemistry, Biochemistry, or related field required
10+ years of experience in Regulatory Affairs or related pharmaceutical industry roles
Expertise in CMC regulatory requirements and submission processes
Strong leadership and collaboration skills with ability to influence stakeholders
Excellent organizational and communication skills
Ability to manage complex projects and meet tight timelines
Knowledge of global regulatory frameworks (FDA, EMA, Health Canada)
Preferred
advanced degree preferred
Benefits
An agile career and dynamic working culture.
An inclusive and ethical workplace.
Compensation programs that recognize high performance.
A variety of benefits dependent on role and location.
Company
Lonza
Lonza Group supplies products and services to pharmaceutical and agrochemical industries.
Funding
Current Stage
Public CompanyTotal Funding
$444.8M2023-11-06Post Ipo Debt· $444.8M
2020-12-07IPO
Recent News
2025-12-17
Company data provided by crunchbase